BioSyntech, Inc. · Laval, QC Canada
Key BioSyntech, Inc. Financials
| Company Type | Private -
|
|---|
| Fiscal Year-End | March |
|---|
| 2009 Sales (mil.) | $0.0 |
|---|
For a Hoover's Free Trial, Call
(866) 444-8642
or
Chat Now
BioSyntech, Inc. Income Statement
| Mar 09 | Mar 08 | Mar 07 |
| Revenue | 0.0 | 0.3 | 0.2 |
| Cost of Goods Sold | 0.0 | 0.1 | 0.1 |
| Gross Profit | 0.0 | 0.2 | 0.1 |
| Gross Profit Margin | 60.8% | 62.8% | 63.1% |
| SG&A Expense | 2.4 | 3.6 | 3.3 |
| Depreciation & Amortization | 0.3 | 0.5 | 0.4 |
| Operating Income | (10.4) | (9.0) | (7.2) |
| Operating Margin | -31739.1% | -3358% | -3423.2% |
| Nonoperating Income | -- | 0.0 | 0.0 |
| Nonoperating Expenses | (1.0) | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (10.4) | (9.0) | (7.0) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (10.4) | (9.0) | (7.0) |
| Total Net Income | (10.4) | (9.0) | (7.0) |
| Net Profit Margin | -31739.1% | -3372.2% | -3332.4% |
| Diluted EPS from Total Net Income | (0.10) | (0.10) | (0.08) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
BioSyntech, Inc. Balance Sheet
| Assets | Mar 09 | Mar 08 | Mar 07 |
| Current Assets |
| Cash | 3.0 | 2.8 | 3.5 |
| Net Receivables | 0.2 | 0.1 | 0.1 |
| Inventories | 0.0 | 0.0 | 0.0 |
| Other Current Assets | 1.0 | 0.9 | 7.7 |
| Total Current Assets | 4.3 | 3.8 | 11.3 |
| Net Fixed Assets | 1.5 | 2.1 | 2.1 |
| Other Noncurrent Assets | 0.0 | 0.6 | 0.8 |
| Total Assets | 5.8 | 6.6 | 14.2 |
| Liabilities | Mar 09 | Mar 08 | Mar 07 |
| Current Liabilities |
| Accounts Payable | 0.4 | 0.6 | 0.5 |
| Short-Term Debt | 8.1 | 0.5 | 0.5 |
| Other Current Liabilities | 1.0 | 0.7 | 0.7 |
| Total Current Liabilities | 9.5 | 1.9 | 1.7 |
| Long-Term Debt | 1.6 | 2.5 | 2.9 |
| Other Noncurrent Liabilities | 0.0 | 0.0 | 0.0 |
| Total Liabilities | 11.1 | 4.4 | 4.5 |
| Shareholder's Equity |
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | (5.3) | 2.2 | 9.7 |
| Total Equity | (5.3) | 2.2 | 9.7 |
| Shares Outstanding (thou.) | 96,087.0 | 95,487.0 | 95,487.0 |
All amounts in millions of US Dollars except per share amounts.
BioSyntech, Inc. Cash Flow Statement
| Mar 09 | Mar 08 | Mar 07 |
| Net Operating Cash Flow | (8) | (8) | (7) |
| Net Investing Cash Flow | (0.2) | 7.5 | (1.7) |
| Net Financing Cash Flow | 8.6 | (0.6) | 7.7 |
| Net Change in Cash | 0.8 | (1.2) | (0.5) |
| Depreciation & Amortization | 0.3 | 0.5 | 0.4 |
| Capital Expenditures | (0.2) | (0.2) | (0.2) |
| Cash Dividends Paid | | | |
All amounts in millions of US Dollars except per share amounts.
